EBV Testing Guidelines

Primary Indications for EBV Testing

The Infectious Diseases Society of America recommends EBV testing in patients with clinical features suggestive of infectious mononucleosis but have a negative heterophile antibody test, or when evaluating for EBV-associated lymphoproliferative disease in immunocompromised patients 1, 2
EBV testing should be considered in immunocompromised patients, such as transplant recipients, HIV-infected individuals, and those with congenital immunodeficiencies, who are at risk for EBV-associated lymphoproliferative disease 1, 2
The Centers for Disease Control and Prevention suggests considering EBV testing when evaluating patients with cerebrospinal fluid abnormalities and suspected CNS lymphoma, particularly in immunocompromised patients 1, 3

Specific EBV Serologic Testing Approach

The American College of Physicians recommends ordering an EBV-specific antibody panel, including IgG and IgM to viral capsid antigen (VCA) and antibodies to Epstein-Barr nuclear antigen (EBNA), when heterophile tests are negative but EBV infection is still suspected 1
The presence of VCA IgM (with or without VCA IgG) antibodies in the absence of EBNA antibodies indicates recent primary EBV infection, according to the Infectious Diseases Society of America 1
The presence of EBNA antibodies indicates infection occurring more than 6 weeks prior to testing, making EBV unlikely as the cause of current symptoms, as stated by the Clinical Infectious Diseases society 1, 2

Testing in Special Populations

The Pediatric Infectious Diseases Society notes that in children under 10 years, heterophile antibody tests have higher false-negative rates, making EBV-specific antibody testing more important 1
For immunocompromised patients with suspected EBV-associated lymphoproliferative disease, the Infectious Diseases Society of America recommends quantitative EBV viral load testing by nucleic acid amplification test (NAAT) in peripheral blood 1, 2

Specimen Collection and Timing

The Clinical and Laboratory Standards Institute recommends collecting serum specimens as soon as possible after symptom onset for serologic testing 1, 4
The World Health Organization suggests that for EBV DNA detection, appropriate specimens include whole blood, peripheral blood lymphocytes, or plasma (EDTA tube, room temperature, transported within 2 hours) 4
The Centers for Disease Control and Prevention recommends that for CNS involvement, cerebrospinal fluid should be collected in a sterile tube and transported at room temperature within 2 hours 4

Diagnostic Approach to EBV Infection

Understanding EBV and Lymphocyte Response

EBV infection commonly presents with an elevated white blood cell count with increased percentage of atypical lymphocytes, which is a hallmark of EBV-associated mononucleosis 5, 6

Diagnostic Algorithm for EBV Infection

Initial diagnosis should include heterophile antibody test and complete blood count with differential 7
If clinical suspicion remains high after a negative Monospot test, perform EBV-specific serologic testing for IgG and IgM antibodies to viral capsid antigen and antibodies to Epstein-Barr nuclear antigen 5, 7
Recent primary EBV infection is indicated by positive VCA IgM and negative EBNA antibodies 5, 6

Monitoring Considerations

In immunocompetent patients, routine monitoring beyond 4-6 weeks is generally not necessary unless symptoms persist 5, 6
In immunocompromised patients, more frequent monitoring is recommended due to risk of lymphoproliferative disease 8

Common Pitfalls to Avoid

Overlooking the need for differential diagnosis of mononucleosis-like illnesses caused by other pathogens if lymphocyte patterns are atypical 5, 6

Diagnostic Testing for Infectious Mononucleosis

Recommended Diagnostic Approach

The Infectious Diseases Society of America (IDSA) does not list throat swabs as a diagnostic method for EBV infection 9

EBV Detection and Diagnosis

EBV can be detected in throat secretions, but this finding does not confirm acute infection as the virus can persist in the throat for weeks to months after infection 10
The presence of EBV in throat samples must be interpreted cautiously, as it may represent prolonged excretion rather than acute infection 10

EBV Exposure Testing Recommendations

Primary Testing Approach

The Infectious Diseases Society of America recommends that for suspected acute EBV infection, begin with a heterophile antibody test, and if negative but clinical suspicion remains high, proceed immediately to EBV-specific antibody testing including VCA IgM, VCA IgG, and EBNA antibodies 11, 12

Special Populations

For transplant recipients, HIV-infected individuals, and those with congenital immunodeficiencies, the Infectious Diseases Society of America recommends quantitative EBV viral load testing by nucleic acid amplification test (NAAT) rather than relying solely on serology 11, 12
The American Journal of Hematology suggests that EBV DNA levels > 10^2.5 copies/mg DNA in peripheral blood mononuclear cells indicate active infection 13

Diagnostic Interpretation

The presence of EBNA antibodies indicates past infection, which develops 1-2 months after primary infection and persists for life, making EBV unlikely as the cause of current acute symptoms 11, 12
The absence of EBNA antibodies in 5-10% of infected patients should be considered when interpreting test results 11, 12

CNS Involvement

For suspected EBV-associated encephalitis, the Infectious Diseases Society of America recommends both CSF PCR and serology (VCA IgM/IgG and EBNA) should be performed 14

EBV Infection Diagnosis and Interpretation

Special Considerations in EBV Infection

The American Academy of Hematology recommends quantitative EBV viral load testing by nucleic acid amplification (NAAT) for immunocompromised patients, such as transplant recipients and HIV-infected individuals, rather than relying solely on serology 15, 16
Chronic Active EBV Infection (CAEBV) diagnosis requires persistent IM-like symptoms, unusual antibody patterns, and exclusion of other disease processes, with positive IgA antibodies to VCA and/or EA often demonstrated 15, 16

Diagnostic Approaches for CAEBV

Unusual antibody patterns with markedly elevated anti-VCA (≥1:640) and anti-EA (≥1:160) suggest CAEBV, according to the American Journal of Hematology 15, 16

Diagnostic Considerations for EBV Infection

Test Performance and Interpretation

A positive Monospot test is considered diagnostic for EBV infection and no further EBV-specific testing is required, according to the Clinical Infectious Diseases guidelines 17
A negative Monospot test does not rule out EBV infection, particularly in children under 10 years or during the first week of symptoms, as stated by the Clinical Infectious Diseases guidelines 17
If the initial Monospot test is negative but clinical suspicion remains high, the test can be repeated on a serum specimen obtained 7-10 days later, at which time the heterophile antibodies are more likely to be positive if EBV infection is present, as recommended by the Clinical Infectious Diseases guidelines 17
When the Monospot is negative but clinical suspicion remains high, perform EBV-specific serologic testing for VCA IgM, VCA IgG, and EBNA antibodies on the same sample, as suggested by the Clinical Infectious Diseases guidelines 17

EBV Infection Diagnosis and Management

Diagnostic Criteria and Interpretation

The American Journal of Hematology recommends that EBV DNA >10^2.5 copies/mg DNA in peripheral blood mononuclear cells indicates active infection in immunocompromised patients 18
The American Journal of Hematology suggests that patients with persistent symptoms >10 days with fever, lymphadenopathy, hepatosplenomegaly should be evaluated for Chronic Active EBV Infection (CAEBV) 19
The diagnostic criteria for CAEBV includes persistent IM-like symptoms + markedly elevated VCA IgG (≥1:640) and EA IgG (≥1:160) + EBV DNA >10^2.5 copies/mg in peripheral blood 18, 19

Clinical Management

The American Journal of Hematology recommends monitoring for complications such as hepatosplenomegaly, airway obstruction, severe hepatitis in uncomplicated infectious mononucleosis patients 19
The American Journal of Hematology suggests that markedly elevated transaminases (>10x normal) should be considered as EBV-associated acute hepatitis 19

Chronic Active EBV Infection Diagnosis

Serologic Markers

Elevated EA‑D antibody titers (≥ 1:160) together with very high VCA IgG titers (≥ 1:640) strongly indicate chronic active EBV infection. 20
IgA‑class antibodies to VCA and/or EA are frequently present in chronic active EBV infection and provide supportive diagnostic evidence. 21

Diagnostic Criteria

A combination of VCA IgG ≥ 1:640, EA IgG ≥ 1:160, persistent mononucleosis‑like symptoms, and a positive IgA response to VCA or EA fulfills the diagnostic criteria for chronic active EBV infection. 21